Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival

Proteomics

Volumn 6, Issue 11, 2006, Pages 3466-3476

  Kim, Hyunki ^a   Kang, Hyun Ju ^a   You, Kwon Tae ^a   Kim, Se Hoon ^a   Lee, Kang Young ^a   Kim, Tae Il ^a   Kim, Chul ^a   Song, Si Young ^a   Kim, Hye Jung ^b   Lee, Cheolju ^b   Kim, Hoguen ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Biomarker; Colorectal carcinoma; Prognosis; Selenium binding protein 1

Indexed keywords

SELENIUM BINDING PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEMETHYLATION; DOWN REGULATION; FEMALE; GENE DELETION; GENE MUTATION; GENE REPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADENOMA; CARCINOMA; COLON; COLORECTAL NEOPLASMS; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; INTESTINAL MUCOSA; PROGNOSIS; PROTEOME; SELENIUM-BINDING PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745076486     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200500629     Document Type: Article

References (25)

1. Stulik, J., Hernychova, L., Porkertova, S., Knizek, J. et al., Electrophoresis 2001, 22, 3019-3025.
2. Friedman, D. B., Hill, S., Keller, J. W., Merchant, N. B. et al., Proteomics 2004, 4, 793-811.
3. Tomonaga, T., Matsushita, K., Yamaguchi, S., Oh-Ishi, M. et al., Clin. Cancer Res. 2004, 10, 2007-2014.
4. Chen, G., Gharib, T. G., Huang, C. C., Thomas, D. G. et al., Clin. Cancer Res. 2002, 8, 2298-2305.
5. Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P. et al., Lancet 2003, 362, 433-439.
6. Li, L. S., Kim, H., Rhee, H., Kim, S. H. et al., Proteomics 2004, 4, 3394-3400.
7. Vercoutter-Edouart, A. S., Lemoine, J., Le Bourhis, X., Louis, H. et al., Cancer Res. 2001, 61, 76-80.
8. Wulfkuhle, J. D., Sgroi, D. C., Krutzsch, H., McLean, K. et al., Cancer Res. 2002, 62, 6740-6749.
9. Park, K. S., Kim, H., Kim, N. G., Cho, S. Y. et al., Hepatology 2002, 35, 1459-1466.
10. Zeindl-Eberhart, E., Haraida, S., Liebmann, S., Jungblut, P. R. et al., Hepatology 2004, 39, 540-549.
11. Choi, Y. R., Kim, H., Kang, H. J., Kim, N. G. et al., Cancer Res. 2003, 63, 2188-2193.
12. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Anal. Chem. 1996, 68, 850-858.
13. Taguchi, A., Blood, D. C., del Toro, G., Canet, A. et al., Nature 2000, 405, 354-360.
14. Flohr, A. M., Rogalla, P., Meiboom, M., Borrmann, L. et al., Anticancer Res. 2001, 21, 3881-3885.
15. Xiang, Y. Y., Wang, D. Y., Tanaka, M., Suzuki, M. et al., Int. J. Cancer 1997, 74, 1-6.
16. Kawahara, N., Tanaka, T., Yokomizo, A., Nanri, H. et al., Cancer Res. 1996, 56, 5330-5333.
17. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H. et al., JAMA 1996, 276, 1957-1963.
18. Fleming, J., Ghose, A., Harrison, P. R., Nutr. Cancer 2001, 40, 42-49.
19. Rayman, M. P., Lancet 2000, 356, 233-341.
20. Yang, M., Sytkowski, A. J., Cancer Res. 1998, 58, 3150-3153.
21. Chen, G., Wang, H., Miller, C. T., Thomas, D. G. et al., J. Pathol. 2004, 202, 321-329.
22. Reid, M. E., Duffield-Lillico, A. J., Garland, L., Turnbull, B. W. et al., Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1285-1291.
23. Zhuo, H., Smith, A. H., Steinmaus, C., Cancer Epidemiol. Biomarkers Prev. 2004, 13, 771-778.
24. Behne, D., Kyriakopoulos, A., Annu. Rev. Nutr. 2001, 27, 453-473.
25. Lanfear, J., Fleming, J., Walker, M., Harrison, P., Carcinogenesis 1993, 14, 335-340.